Search Results
You are looking at 1 - 2 of 2 items for
- Author: Hailong Wang x
- Refine by access: All content x
Search for other papers by Lingling Zhang in
Google Scholar
PubMed
Search for other papers by Shenghui Zhou in
Google Scholar
PubMed
Search for other papers by Beibei Bi in
Google Scholar
PubMed
Search for other papers by Hailong Wang in
Google Scholar
PubMed
Search for other papers by Bingxin Fu in
Google Scholar
PubMed
Search for other papers by Manman Guo in
Google Scholar
PubMed
Search for other papers by Siwei Luo in
Google Scholar
PubMed
Search for other papers by Jung-Chien Cheng in
Google Scholar
PubMed
Search for other papers by Lanlan Fang in
Google Scholar
PubMed
In brief
Cordycepin (COR), a compound derived from Cordyceps, is recognized as an adenosine analog with numerous beneficial effects on human health. However, its impact on steroidogenic acute regulatory protein (STAR) expression in ovarian granulosa cells is not well understood. This study demonstrates that COR downregulates STAR expression by reducing the expression of the SP1 transcription factor.
Abstract
Cordycepin (COR), a pure compound of Cordyceps, is known as an adenosine analog that exerts many beneficial effects on human health. The steroidogenesis mediated by ovarian granulosa cells is pivotal in maintaining normal female reproductive function. The steroidogenic acute regulatory protein (STAR) regulates the rate-limiting step in steroidogenesis. COR has been shown to stimulate STAR expression in mouse Leydig cells, the steroidogenic cells in the testes. However, the effect of COR on STAR expression in ovarian granulosa cells remains undetermined. In the present study, we show that treatment with COR downregulates STAR expression in a steroidogenic human granulosa-like tumor cell line, KGN, and primary culture of human granulosa-lutein (hGL) cells obtained from patients undergoing in vitro fertilization. We used specific adenosine receptor (AR) antagonists, and our results reveal that the inhibitory effect of COR on STAR expression is mediated by AR–A1, AR–A2A, and AR–A3. In both KGN and primary hGL cells, COR activates ERK1/2 and AKT signaling pathways, but only activation of ERK1/2 is required for the COR-induced downregulation of STAR expression. In addition, our results demonstrate that COR downregulates STAR expression by reducing the expression of the SP1 transcription factor. These results provide a better understanding of the biological function of COR on STAR expression in the ovary, which may lead to the development of alternative therapeutic approaches for female reproductive disorders.
Search for other papers by Pan-Pan Cheng in
Google Scholar
PubMed
Search for other papers by Jun-Jie Xia in
Google Scholar
PubMed
Search for other papers by Hai-Long Wang in
Google Scholar
PubMed
Search for other papers by Ji-Bing Chen in
Google Scholar
PubMed
Search for other papers by Fei-Yu Wang in
Google Scholar
PubMed
Search for other papers by Ye Zhang in
Google Scholar
PubMed
Search for other papers by Xin Huang in
Google Scholar
PubMed
Search for other papers by Quan-Jun Zhang in
Google Scholar
PubMed
Search for other papers by Zhong-Quan Qi in
Google Scholar
PubMed
Maternal diabetes adversely affects preimplantation embryo development and oocyte maturation. Thus, it is important to identify ways to eliminate the effects of maternal diabetes on preimplantation embryos and oocytes. The objectives of this study were to investigate whether islet transplantation could reverse the effects of diabetes on oocytes. Our results revealed that maternal diabetes induced decreased ovulation; increased the frequency of meiotic spindle defects, chromosome misalignment, and aneuploidy; increased the relative expression levels of Mad2 and Bub1; and enhanced the sensitivity of oocytes to parthenogenetic activation. Islet transplantation prevented these detrimental effects. Therefore, we concluded that islet transplantation could reverse the effects of diabetes on oocytes, and that this technique may be useful to treat the fundamental reproductive problems of women with diabetes mellitus.